AS
Apurva Singh
About Apurva Singh
Data last updated:
Apurva Singh is a Director at Akimoto Pharmaceuticals Private Limited (since 2023) and Director at Quantz Healthcare And Research Private Limited (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Akimoto Pharmaceuticals Private Limited at ₹60.7 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Jan 2023 | 2023 | ₹60.7 Lakh (FY 2025) | Active | |
| Director | 09 Aug 2024 | 2024 | Active |
Board colleagues of Apurva Singh
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shivam Chaudhary | 09855411 | Akimoto Pharmaceuticals Private Limited | Director |
| Prarthana Saxena | 10733355 | Quantz Healthcare And Research Private Limited | Director |
| Shweta Verma | 10733356 | Quantz Healthcare And Research Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Apurva Singh
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Apurva Singh
Apurva Singh currently holds 2 directorships: Akimoto Pharmaceuticals Private Limited (Director, since 09 Jan 2023, revenue ₹60.7 Lakh (FY 2025)); Quantz Healthcare And Research Private Limited (Director, since 09 Aug 2024).
Apurva Singh was first appointed on 09 Jan 2023 as Director at Akimoto Pharmaceuticals Private Limited. The most recent appointment on record is 09 Aug 2024 at Quantz Healthcare And Research Private Limited.
The current boards of Apurva Singh's companies include Shivam Chaudhary (Akimoto Pharmaceuticals Private Limited), Prarthana Saxena (Quantz Healthcare And Research Private Limited), Shweta Verma (Quantz Healthcare And Research Private Limited).